Lv11
50 积分 2022-04-12 加入
Mitigating Limited Data Challenges to Improve Artificial Intelligence Integration in Rare Disease Drug Development
8小时前
求助中
Trends in FDA Data Integrity Enforcement Before and After the COVID-19 Pandemic: An Analysis of 1766 Warning Letters (2016–2023)
1个月前
已完结
EXPRESS: Are All Generic Drugs Created Equal? An Empirical Analysis of Generic Drug Manufacturing Location and Serious Drug Adverse Events
3个月前
已完结
Model-based approach for two-stage group sequential or adaptive designs in bioequivalence studies using parallel and crossover designs
3个月前
已完结
Isotretinoin Risk Evaluation and Mitigation Strategy and Pregnancy Incidence
3个月前
已完结
New medicines for childhood-onset systemic lupus erythematosus: an EU perspective on paediatric drug development
3个月前
已完结
Oncology “Me-Too” Drugs Compared With Original Drugs in Randomized Clinical Trials
3个月前
已完结
Proceedings: PET Drugs—A 2023 Workshop on Product Quality, Regulatory Submissions, Facility Inspections, and Benefit–Risk Considerations
3个月前
已完结
Proceedings: PET Drugs-A 2023 Workshop on Product Quality, Regulatory Submissions, Facility Inspections, and Benefit-Risk Considerations
3个月前
已完结
Microwave Radiations: A Green Approach to the Synthesis of Five- Membered Heterocyclic Compounds
1年前
已完结
Whirlwind Acoustic Vortex‐Regulated Intelligent Microbots for Enhanced Uniform Drug Bioaccumulation to Boost Systemic Immunity Against Large Tumors
皖公网安备34019202002308
